Jiang, Y., Zheng, R., & Sang, H. (2021). Cost-Effectiveness of Adding SGLT2 Inhibitors to Standard Treatment for Heart Failure With Reduced Ejection Fraction Patients in China. Frontiers Media S.A.
Cita Chicago Style (17a ed.)Jiang, Yaohui, Rujie Zheng, y Haiqiang Sang. Cost-Effectiveness of Adding SGLT2 Inhibitors to Standard Treatment for Heart Failure With Reduced Ejection Fraction Patients in China. Frontiers Media S.A, 2021.
Cita MLA (8a ed.)Jiang, Yaohui, et al. Cost-Effectiveness of Adding SGLT2 Inhibitors to Standard Treatment for Heart Failure With Reduced Ejection Fraction Patients in China. Frontiers Media S.A, 2021.
Precaución: Estas citas no son 100% exactas.